Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of TAK-536 in hypertensive patients with renal disorder
jRCT2080220835Phase 3
- Sponsor
- Takeda
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azilsartan in hypertension (HTN) and Not applicable, sponsored by Takeda.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)Not applicable
Beyond the preview
Go deeper on jRCT2080220835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220835.